Home > PS Ratio > BLISS GVS PHARMA

BLISS GVS PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of BLISS GVS PHARMA is 2.00.

Share Price ₹151.8Dec 11,2024
Market Cap ₹1,600.0 Cr
Sales-TTM₹800.2 CrTTM-Consolidated Results
Price/Sales2.00xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BLISS GVS PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BLISS GVS PHARMA is calculated as :

Current Market Cap [ ₹1,600.0 Cr] as on Dec 11,2024

(/) Sales [ ₹800.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.00x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BLISS GVS PHARMA , the investors are currently willing to pay '2.00 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BLISS GVS PHARMA !

The chart below summarizes the trend in P/S Ratio of BLISS GVS PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of BLISS GVS PHARMA


PS Ratio Performance Analysis for BLISS GVS PHARMA

- BLISS GVS PHARMA 's latest p/e ratio is 2.00x.

- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.37x.

- BLISS GVS PHARMA 's operated at median p/e ratio of 1.51x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2021 at 1.76x.

- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0.99x.


How does BLISS GVS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BLISS GVS PHARMA 800.22.001,600.0
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.61432,948.0
CIPLA LTD26,512.04.41116,809.0
DR REDDYS LABORATORIES LTD30,084.93.46103,963.0
ZYDUS LIFESCIENCES LTD21,483.54.5798,173.2
DIVIS LABORATORIES LTD8,614.018.33157,873.0
MANKIND PHARMA LTD11,018.09.64106,198.0
TORRENT PHARMACEUTICALS LTD11,225.010.04112,643.0
LUPIN LTD21,431.34.5196,581.6
AUROBINDO PHARMA LTD30,295.02.3370,576.1
ABBOTT INDIA LTD6,066.110.0661,032.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BLISS GVS PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.00x
Max industry PS 18.33x
Median industry PS 4.57x
Average industry PS 7.09x



You may also like the below Video Courses